Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Intraseptal and Periodontal Ligament Anaesthesia for Tooth Extraction in Patients With Type 2 Diabetes

13. juni 2026 oppdatert av: Vladimir Biocanin, University of Business Academy in Novi Sad, Serbia

Efficacy and Safety of Intraseptal and Periodontal Ligament Anaesthesia for Extraction of Upper Lateral Incisors and Lower First Premolars in Patients With Type 2 Diabetes Mellitus

The goal of this clinical trial is to compare two local anesthesia techniques, intraseptal anesthesia (ISA) and periodontal ligament anesthesia (PLA), in patients with controlled type 2 diabetes mellitus undergoing tooth extraction.

The main questions it aims to answer are:

Which technique provides more effective local anesthesia for tooth extraction? Do ISA and PLA differ in their effects on blood pressure and heart rate during the procedure?

Researchers will compare ISA and PLA to determine which method is more effective and safer in this patient population.

Participants will:

Receive local anesthesia (ISA or PLA) using articaine with epinephrine delivered with a computer-controlled system Undergo extraction of a maxillary lateral incisor or mandibular first premolar Have blood pressure and heart rate measured before, during, and after anesthesia and extraction

Studieoversikt

Detaljert beskrivelse

This randomized clinical trial was designed to evaluate and compare the clinical efficacy and safety of intraseptal anesthesia (ISA) and periodontal ligament anesthesia (PLA) in patients with controlled type 2 diabetes mellitus undergoing tooth extraction.

Local anesthetic administration in diabetic patients requires careful consideration due to potential cardiovascular responses and altered tissue sensitivity. Alternative injection techniques such as ISA and PLA may provide effective anesthesia while minimizing systemic effects.

A total of 120 participants were randomly assigned to receive either ISA or PLA. All anesthetic procedures were performed using a computer-controlled local anesthetic delivery system (CCLADS) with 0.6 mL of 4% articaine with 1:100,000 epinephrine (Septanest).

The study included extraction of maxillary lateral incisors and mandibular first premolars. Outcomes included anesthetic success rate, onset time, duration and extent of anesthesia, as well as changes in systolic and diastolic blood pressure, mean arterial pressure, and heart rate measured before, during, and after the procedure.

Studietype

Intervensjonell

Registrering (Faktiske)

120

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Vojvodina
      • Pančevo, Vojvodina, Serbia
        • Faculty of Dentistry in Pančevo, University of Business Academy in Novi Sad

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Controlled Type 2 diabetes mellitus
  • Age 35-77 years
  • Patients requiring extraction of maxillary lateral incisors or mandibular first premolars
  • Teeth free of acute periodontal disease
  • No acute dentoalveolar abscess
  • No dental treatment within last 48 hours
  • No smoking
  • No alcohol or drug dependence
  • No contraindications to local anesthetic or vasoconstrictor

Exclusion Criteria:

  • Smokers
  • Patients with alcohol or drug dependence
  • Contraindications to local anesthetics or vasoconstrictors
  • Acute periodontal disease at the site of injection
  • Acute dentoalveolar abscess
  • History of tooth trauma or hypersensitivity in target teeth
  • Dental treatment within the last 48 hours prior to procedure
  • Non-controlled diabetes mellitus (implied, since study includes controlled DM only

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: ISA (Intraseptal Anaesthesia)
Participants received intraseptal anaesthesia using 0.6 mL of 4% articaine with 1:100,000 epinephrine administered via a computer-controlled local anesthetic delivery system (CCLADS) during extraction of maxillary lateral incisors or mandibular first premolars.
0.6 mL of 4% articaine with 1:100,000 epinephrine administered for intraseptal anaesthesia (ISA) using a computer-controlled local anesthetic delivery system (CCLADS) during extraction of maxillary lateral incisors or mandibular first premolars.
Eksperimentell: PLA (Periodontal Ligament Anaesthesia)
Participants received periodontal ligament anaesthesia using 0.6 mL of 4% articaine with 1:100,000 epinephrine administered via a computer-controlled local anesthetic delivery system (CCLADS) during extraction of maxillary lateral incisors or mandibular first premolars.
0.6 mL of 4% articaine with 1:100,000 epinephrine administered for periodontal ligament anaesthesia (PLA) using a computer-controlled local anesthetic delivery system (CCLADS) during extraction of maxillary lateral incisors or mandibular first premolars.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Anesthetic success rate
Tidsramme: During tooth extraction procedure (5 minutes after administration of local anaesthesia).
Anesthetic success rate of intraseptal anaesthesia (ISA) compared with periodontal ligament anaesthesia (PLA) during extraction of maxillary lateral incisors and mandibular first premolars in patients with controlled Type 2 diabetes mellitus.
During tooth extraction procedure (5 minutes after administration of local anaesthesia).

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Onset time of local anesthesia
Tidsramme: Immediately after administration of local anesthesia (during procedure)
Time from completion of anesthetic injection to the establishment of profound anesthesia in adjacent gingival tissue.
Immediately after administration of local anesthesia (during procedure)
Duration of soft tissue anesthesia
Tidsramme: During and after procedure (measured at 5-minute intervals until sensation returns)
Time period from onset of anesthesia until return of sensation confirmed by pinprick testing in buccal attached gingiva.
During and after procedure (measured at 5-minute intervals until sensation returns)
Width of anesthetic field
Tidsramme: 10 minutes after successful anesthesia
Extent (in millimeters) of anesthetized area in buccal/lingual/palatal attached gingiva and oral mucosa measured using pinprick testing and a flexible ruler.
10 minutes after successful anesthesia
Systolic blood pressure changes
Tidsramme: Baseline, during injection, and 5, 10, 15, and 30 minutes post-injection
Changes in systolic blood pressure before, during, and after administration of local anesthesia.
Baseline, during injection, and 5, 10, 15, and 30 minutes post-injection
Diastolic blood pressure changes
Tidsramme: Baseline, during injection, and 5, 10, 15, and 30 minutes post-injection
Changes in diastolic blood pressure during perioperative period of anesthesia administration.
Baseline, during injection, and 5, 10, 15, and 30 minutes post-injection
Mean arterial pressure changes
Tidsramme: Baseline to 30 minutes post-injection
Changes in mean arterial pressure during and after administration of local anesthesia.
Baseline to 30 minutes post-injection
Heart rate changes
Tidsramme: Baseline, during injection, and 5, 10, 15, 30 minutes after administration
Changes in heart rate during and after administration of local anesthesia using ECG monitoring.
Baseline, during injection, and 5, 10, 15, 30 minutes after administration

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Vladimir Biocanin, Faculty of Dentistry in Pancevo, Department of Oral Surgery, University of Business Academy in Novi Sad, Serbia

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

11. januar 2026

Primær fullføring (Faktiske)

17. april 2026

Studiet fullført (Faktiske)

27. mai 2026

Datoer for studieregistrering

Først innsendt

9. juni 2026

Først innsendt som oppfylte QC-kriteriene

9. juni 2026

Først lagt ut (Faktiske)

15. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

16. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

13. juni 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

IPD will not be shared in order to protect participant privacy and ensure compliance with data protection regulations. Only summarized data will be made available in published results.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

produkt produsert i og eksportert fra USA

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere